Jillian B. Thomsen is CAO & VP at NEKTAR THERAPEUTICS (NKTR). They have made 39 open-market trades across 1 company since 2008, most recently 2023-02-16.
CIK 0001433457
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 39 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NKTR | 313,497 | $11.2M |
Shares reported on the most recent Form 4, priced at the 2023-02-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NKTR | SELL | 2023-02-16 | 2023-02-17 | $3.00 | $31K | -49.2% | -69.3% | -77.9% |
| NKTR | SELL | 2022-11-16 | 2022-11-18 | $3.57 | $40K | -16.0% | -28.9% | -13.1% |
| NKTR | SELL | 2022-08-16 | 2022-08-17 | $4.76 | $10K | -7.8% | -25.2% | -15.5% |
| NKTR | SELL | 2022-05-16 | 2022-05-17 | $3.95 | $23K | -7.6% | -15.4% | +28.2% |
| NKTR | SELL | 2022-02-16 | 2022-02-18 | $10.95 | $26K | +2.4% | -45.0% | -62.2% |
| NKTR | SELL | 2021-11-16 | 2021-11-17 | $13.16 | $177K | -11.4% | +7.6% | -12.0% |
| NKTR | SELL | 2021-08-16 | 2021-08-18 | $13.83 | $369K | +12.9% | +23.0% | -1.0% |
| NKTR | SELL | 2021-05-17 | 2021-05-19 | $18.30 | $490K | -0.6% | -6.5% | -24.8% |
| NKTR | SELL | 2021-02-16 | 2021-02-18 | $22.37 | $524K | -5.0% | -10.5% | -26.2% |
| NKTR | SELL | 2021-01-28 | 2021-01-29 | $18.62 | $1.4M | +0.9% | +2.7% | -12.7% |
| NKTR | SELL | 2020-11-16 | 2020-11-18 | $16.93 | $406K | -3.4% | +10.0% | +31.7% |
| NKTR | SELL | 2020-08-17 | 2020-08-19 | $19.67 | $27K | +1.3% | +5.6% | -8.1% |
| NKTR | SELL | 2020-05-18 | 2020-05-20 | $22.51 | $31K | -5.1% | -0.6% | -15.1% |
| NKTR | SELL | 2020-02-18 | 2020-02-20 | $22.35 | $31K | -17.3% | -31.6% | -2.2% |
| NKTR | SELL | 2020-02-06 | 2020-02-07 | $22.78 | $854K | +6.6% | -20.2% | -10.5% |
| NKTR | SELL | 2019-11-18 | 2019-11-20 | $17.97 | $49K | -1.8% | +7.6% | +11.3% |
| NKTR | SELL | 2019-08-16 | 2019-08-19 | $18.15 | $33K | -2.7% | +12.7% | +1.0% |
| NKTR | SELL | 2019-05-16 | 2019-05-17 | $31.37 | $121K | +0.5% | +5.5% | -43.0% |
| NKTR | SELL | 2019-02-19 | 2019-02-21 | $42.39 | $153K | -5.4% | -20.2% | -17.5% |
| NKTR | SELL | 2019-02-04 | 2019-02-06 | $42.16 | $1.4M | -2.8% | -20.3% | -27.2% |
| NKTR | SELL | 2018-11-16 | 2018-11-19 | $38.25 | $154K | +10.0% | -6.7% | +16.6% |
| NKTR | SELL | 2018-05-16 | 2018-05-18 | $83.39 | $596K | -6.3% | -31.8% | -30.0% |
| NKTR | SELL | 2018-04-16 | 2018-04-18 | $101.46 | $2.8M | -9.6% | -7.8% | -47.7% |
| NKTR | SELL | 2018-02-16 | 2018-02-20 | $82.94 | $422K | +23.6% | +24.9% | +0.3% |
| NKTR | SELL | 2017-08-16 | 2017-08-18 | $19.32 | $102K | +8.6% | +25.8% | +150.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.